Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1Gastrointestinal 1CNS 1

Conditions

Colorectal Neoplasms 5Cholangiocarcinoma 4Stomach Neoplasms 2Rectal Neoplasms 2Gallbladder Neoplasms 2Colonic Neoplasms 2Biliary Tract Neoplasms 2Adenocarcinoma Of Esophagus 2Ovarian Neoplasms 1Esophageal Neoplasms 1Endometrial Neoplasms 1Disease Progression 1Central Nervous System Neoplasms 1Carcinoma, Hepatocellular 1Bile Duct Neoplasms 1Advanced Rectal Cancer 1

Interventions

Biopsy 5X-Rays 4Specimen Handling 4Phantoms, Imaging 4Nuclear Medicine Department, Hospital 4Magnetic Resonance Spectroscopy 4larotrectinib 2erdafitinib 2ensartinib 2cabozantinib 2Topotecan 2ulixertinib 1tipifarnib 1tazemetostat 1selpercatinib 1palbociclib 1olaparib 1niraparib 1ivosidenib 1elacestrant 1alectinib 1abemaciclib 1Vincristine 1Vinblastine 1Vemurafenib 1Temozolomide 1RAD1901 1Paclitaxel 1Methotrexate 1LY3023414 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Central Nervous System Neoplasms × Folfox protocol × 30 days × Clear all
NCT06840886 2026-05-14

A Study of PHST001 in Advanced Solid Tumors

Pheast Therapeutics

Phase 1 Recruiting
272 enrolled
CNSGastrointestinalGynecologic

Ovarian Neoplasms, Central Nervous System Neoplasms, Endometrial Neoplasms, Cholangiocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡